REQUEST A DEMO
Total
USD $0.00
Search more companies

Dallas Drugs Private Limited (India)

Main Activities: All Other Food Manufacturing
Full name: Dallas Drugs Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Dallas Drugs Private Limited is based in India, with the head office in Chandigarh. The enterprise currently operates in the All Other Food Manufacturing sector. It was first established on April 25, 2012. It currently has a total number of 25 (2025) employees. From the latest financial highlights, Dallas Drugs Private Limited reported a net sales revenue increase of 137.7% in 2025. Its’ total assets recorded a growth of 24.81%. In, 2025, the company’s net profit margin increased by 0.18%.

Legal Address
Sco No. 805, 1St Floor (Half Portion At 1St Floor) N.A.C Manimajra,
Chandigarh; Punjab; Postal Code: 160002

Contact Details: Purchase the Dallas Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Dallas Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Dallas Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Dallas Drugs Private Limited report to view the information.
Incorporation Date:
April 25, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Dallas Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
137.7%
Total Operating Revenue
138.12%
Operating Profit
15.78%
EBITDA
6.06%
Net Profit/Loss for the Period
166.91%
Total Assets
24.81%
Total Equity
39.44%
Operating Profit Margin
-15.7%
Net Profit Margin
0.18%
Return on Equity (ROE)
13.5%
Debt / Equity
-855.74%
Quick Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?